Exerkines as an Inter-Organ Communication System

Table of Contents

  1. Exerkines as Communication Molecules
  2. The Tissue-Tissue Map of Exerkine Signalling
  3. Acute Bouts of Exercise – The Exerkine Pulse
  4. Chronic Adaptation – Shaping the Baseline
  5. Clinical Targets – From Mediator to Medication
  6. Synthesis – Unifying the Lecture Series

1 Exerkines as Communication Molecules

Definition

The function of exerkines is to “communicate” with other tissues and organs — adipose tissue, liver, brain, gut, bone, and the gastrointestinal tract — through endocrine, paracrine and autocrine pathways [1, 2].

Acute bouts of exercise release transient exerkine pulses that re-set tissue states; chronic exercise programmes reshape the baseline by altering the resting expression and secretion of exerkines [1, 2].

Why the Inter-Organ Framing Matters

The traditional view of exercise as a “muscle and cardiovascular” phenomenon understates the biology. Modern data — including the MoTrPAC atlas (Lecture 1) — show that nearly every tissue responds:

  • Skeletal muscle — direct contraction-driven adaptations.
  • Adipose tissue — lipolysis, adipokine secretion, browning.
  • Liver — fatty acid oxidation, hepatokine release.
  • Brain — BDNF release, hippocampal plasticity, mood regulation.
  • Gut — microbiome shifts, SCFA production, barrier integrity.
  • Bone — osteocalcin release, increased mineral density.
  • Heart — anti-fibrotic effects, improved contractility.
  • Immune system — cell trafficking, cytokine balance.

The exerkine framework is the connective tissue: it explains how muscle contraction produces effects in organs that did not move.


2 The Tissue-Tissue Map of Exerkine Signalling

A Working Diagram

The simplest accurate map of exerkine signalling has skeletal muscle at the centre and emits signals to all major organs:

Sending tissueRepresentative exerkineReceiving tissueFunctional effect
Skeletal muscleIL-6Liver, adipose, brainEnergy allocation, gluconeogenesis, lipolysis, satiety
Skeletal muscleIL-15AdiposeAnti-adipogenic, fat-mass control
Skeletal muscleIrisinAdipose, brainBrowning, neuroprotection
Skeletal muscleBDNFBrainSynaptic plasticity, mood, cognition
AdiposeAdiponectinLiver, muscleInsulin sensitisation, anti-inflammatory
AdiposeFGF21Liver, brainMetabolic regulation, satiety
LiverFGF21 (hepatokine)Adipose, brainWhole-body metabolic regulation
LiverFollistatinMuscleMyostatin antagonism, muscle growth
LiverGDF15Brain (area postrema)Appetite suppression, stress response
BoneOsteocalcin (undercarboxylated)Muscle, pancreas, brainInsulin secretion, cognitive effects
GutSCFAs (microbial)Immune system, liverBarrier integrity, anti-inflammatory tone
Cardiac muscleANP / BNPVascular, kidneyVolume regulation

Table 1. Representative exerkines with sending tissue, receiving tissue, and functional effect (selected examples) [1, 2].

Communication Distance and Mode

  • Autocrine — feedback on the secreting cell (e.g., muscle IL-6 acting on the myocyte itself).
  • Paracrine — local action on neighbouring cells (e.g., on resident macrophages).
  • Endocrine — systemic action on distant organs (the dominant mode for inter-organ signalling).
  • Extracellular vesicle (EV) cargo — packaged miRNAs, proteins and metabolites carried in EVs across tissues.

The EV mode in particular is a frontier area: exerkine-bearing EVs may carry tissue-specific cargoes and provide a finer-grained signalling system than soluble factors alone (cf. Lecture 3, Ringleb et al.).


3 Acute Bouts of Exercise – The Exerkine Pulse

A Single Bout

A single bout of moderate-to-vigorous exercise releases exerkines in a characteristic temporal pattern (cf. Lecture 8, Table 1):

  1. Catecholamines, glucagon within seconds — mobilising fuel.
  2. Myokines (IL-6, IL-15) over minutes to hours — communicating muscle state.
  3. Hepatokines and adipokines over hours — coordinating the systemic response.
  4. Anti-inflammatory mediators (IL-10, IL-1Ra) following the IL-6 surge — closing the response loop.

The pulse re-tunes target tissues for hours after the bout. Repeated pulses, separated by rest, accumulate into the chronic adaptations described in Section 4.

Dose and Mode Effects

Exerkine release is dose-dependent and modality-dependent:

  • Endurance vs. resistance — endurance favours IL-6 and adipokine responses; resistance favours muscle-growth signals (decreased myostatin, increased follistatin, IL-15).
  • Acute vs. chronic — the same exerkine has different magnitudes acutely vs. chronically; some increase with chronic training, others decrease.
  • Intensity — high-intensity work produces larger acute pulses but with different shapes from prolonged moderate work.

4 Chronic Adaptation – Shaping the Baseline

Trained vs. Untrained

Regular exercise produces measurable shifts in resting exerkine profiles:

  • Lower baseline pro-inflammatory cytokines (TNF-α, IL-6 in inflammatory mode, CRP).
  • Higher baseline adiponectin; lower baseline leptin (relative to fat mass).
  • Higher baseline BDNF (in some studies).
  • More efficient acute responses — same workload produces a smaller perturbation in trained vs. untrained individuals.

Why This Matters Clinically

The chronic-adaptation framing is the biological substrate for nearly every claim in this lecture series:

  • Prediabetes and metabolic syndrome (Lectures 4–5) — reshaped insulin-sensitising adipokine and myokine profiles.
  • MAFLD (Lecture 9) — adipose-driven and hepatokine-mediated reduction in liver fat.
  • IBD (Lectures 10–11) — gut–muscle–immune axis mediated by SCFAs and myokines.
  • Cognitive and mood effects — BDNF and central-acting exerkines.

5 Clinical Targets – From Mediator to Medication

Exerkines as Drug Targets

Several exerkines are active drug-development targets:

  • GLP-1 analogues (semaglutide, tirzepatide) — gut-derived signal pathway exploited for weight loss and diabetes.
  • FGF21 agonists — under clinical investigation for MAFLD and metabolic syndrome.
  • Myostatin / activin antagonists — explored for sarcopenia and muscle-wasting conditions.
  • GDF15 modulators — explored for appetite control.

Why Exercise Remains Distinct

Pharmacological mimicry of single exerkines does not reproduce the coordinated, multi-organ, pulsatile signalling produced by exercise. The pharmacological intervention captures one node of a network; exercise activates the network as a whole.

This is part of the empirical case for the Ashley premise (Lecture 1): exercise does what no single drug can.

Translational Frontiers

Active research questions include:

  1. Can exerkine biomarker panels stratify patients for personalised exercise prescriptions?
  2. Can extracellular vesicle cargoes be used as dose verification for exercise interventions?
  3. Are there non-responder profiles that can be predicted from baseline exerkine biology?
  4. How does ageing alter the exerkine response, and what compensatory strategies could restore youthful signalling (cf. Lecture 3, Ringleb et al.)?

6 Synthesis – Unifying the Lecture Series

The Through-Line

The twelve lectures of this course tell one continuous story:

  1. Lecture 1: Exercise is the most potent medical intervention available — biologically, epidemiologically and economically.
  2. Lecture 2: Sleep and circadian biology are inseparable from exercise effects.
  3. Lecture 3: Exerkines, and IL-6 in particular, allocate energy and communicate between tissues.
  4. Lecture 4: Prediabetes is the early clinical manifestation of inactivity and low-grade inflammation.
  5. Lecture 5: The metabolic syndrome and cardiorespiratory fitness as vital sign.
  6. Lecture 6: Exercise snacks make the prescription accessible to time-poor patients.
  7. Lecture 7: Structured prescription using HRR, HRmax, RPE and MET — DDG-Praxisempfehlung.
  8. Lecture 8: Acute vs. chronic, pro- vs. anti-inflammatory — the biphasic immune response.
  9. Lecture 9: MAFLD as the hepatic face of the metabolic syndrome; HIIT as therapy.
  10. Lecture 10: IBD pathophysiology and the case for exercise as disease-modifying behaviour.
  11. Lecture 11: State-dependent IBD prescription — acute vs. remission.
  12. Lecture 12: The exerkine network as the connecting biology.

The Clinical Take-Home

Exercise prescription is personalised, dose-titrated, multimodal, and integrated with diet and sleep. The exerkine framework is the unifying biology; the clinical translation is in the specific prescriptions of Lectures 4–11.

The competent sports-medicine clinician moves fluidly between this biology and the patient in front of them — diagnosing, dosing, monitoring, and adjusting — and treats exercise with the same precision and respect that they would treat any potent medication.


References

  • [1] Chow LS, Gerszten RE, Taylor JM, Pedersen BK, van Praag H, Trappe S, Febbraio MA, Allen DB, Tweden K, Stein RI, Ravussin E, Goodpaster BH, Snyder MP. Exerkines in health, resilience and disease. Nature Reviews Endocrinology. 2022;18:273–289. doi:10.1038/s41574-022-00641-2.
  • [2] Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiological Reviews. 2008;88(4):1379–1406.
  • [3] Kistner TM, Pedersen BK, Lieberman DE. Interleukin 6 as an energy allocator in muscle tissue. Nature Metabolism. 2022;4(2):170–179.
  • [4] MoTrPAC Study Group. Temporal dynamics of the multi-omic response to endurance exercise training. Nature. 2024;629:174–183.
  • [5] Whitham M, Parker BL, Friedrichsen M, et al. Extracellular vesicles provide a means for tissue cross-talk during exercise. Cell Metabolism. 2018;27(1):237–251.
  • [6] Lourenco MV, Frozza RL, de Freitas GB, et al. Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models. Nature Medicine. 2019;25(1):165–175.
  • [7] Pedersen BK. Anti-inflammatory effects of exercise: role in diabetes and cardiovascular disease. European Journal of Clinical Investigation. 2017;47(8):600–611.

One-Minute-Paper Topics

A One-Minute-Paper (OMP) is a short, focused prompt that students answer in ~60 seconds at the end of a session to consolidate learning, surface misconceptions, and provide formative feedback. When answering, be concise, specific, and use terminology from today’s session.

  1. Define exerkine in one sentence and list three communication modes (autocrine, paracrine, endocrine).
  2. Why is the inter-organ framing necessary for understanding exercise biology? Provide two examples.
  3. Reproduce Table 1: three exerkines with sending tissue, receiving tissue and functional effect.
  4. Distinguish myokines from hepatokines and adipokines. Why does the lecture call them all exerkines?
  5. Describe the four-step temporal pulse of exerkine release after a single bout (catecholamines → myokines → hepatokines / adipokines → resolution mediators).
  6. Explain why dose and modality matter for the exerkine pulse. Compare a 4 × 4 HIIT session with a 60-minute moderate run.
  7. Name three resting-exerkine differences between trained and untrained individuals.
  8. Define an extracellular vesicle and explain why it is a frontier area in exerkine biology.
  9. Why does pharmacological mimicry of a single exerkine fail to reproduce the effect of exercise? Use the Ashley premise (Lecture 1).
  10. Identify three current drug-development targets that overlap with the exerkine framework.
  11. Sketch the gut–muscle–immune axis in five steps. Which exerkine and which microbial metabolite are most prominent?
  12. Why is BDNF important for the cognitive and mood effects of exercise? Which tissue secretes it under exercise stimulation?
  13. Define FGF21 in one sentence. Why is it relevant to both MAFLD (Lecture 9) and metabolic syndrome (Lecture 5)?
  14. Identify two age-related shifts in exerkine biology relevant to Lecture 3 (Ringleb et al.). What strategies could compensate for them?
  15. Discuss the role of irisin in the exerkine network. Why is the literature on its human relevance debated?
  16. Why is the exerkine framework consistent with the MoTrPAC findings (Lecture 1)? Identify two convergent points.
  17. Identify two open translational questions in exerkine biology with clear clinical relevance.
  18. Apply the exerkine framework to a 60-year-old patient with type 2 diabetes, MAFLD and chronic low-grade inflammation. Which exerkine axes are the highest-yield targets?
  19. Summarise the twelve lectures of this course in twelve sentences — one per lecture.
  20. Defend or rebut the Ashley premise — “Exercise may be the single most potent medical intervention ever known” — using exerkine biology and the MoTrPAC atlas as your strongest evidence.